Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTF2F2P1 refers to general transcription factor IIF subunit 2 pseudogene 1, which is a pseudogene related to the protein-coding gene for the general transcription factor IIF (TFIIF) subunit 2. TFIIF itself is a key general transcription factor for RNA polymerase II, essential for both initiation and elongation of mRNA synthesis and composed of two major subunits (RAP74/GTF2F1 and RAP30/GTF2F2)[2][4]. However, as GTF2F2P1 designates a pseudogene, it does not produce a functional protein product and is not considered an active molecular target in cellular processes or therapeutics. Key clarification: - GTF2F2P1 is a pseudogene and does not encode a functional protein or receptor. - The functional general transcription factor is General transcription factor IIF (TFIIF), which consists of active subunits: GTF2F1 (RAP74) and GTF2F2 (RAP30)[2][4]. - TFIIF is an essential general transcription factor, not a drug target in itself, and GTF2F2P1 is not a functional or druggable target. If you need information on the active factor, use General transcription factor IIF subunit 2 (GTF2F2/TFIIF), not the pseudogene GTF2F2P1.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIF subunit 2 pseudogene 1 (GTF2F2P1).